Skip to content

Fusion and disc replacement

TL;DR — Imaging degeneration alone is not an indication for lumbar fusion or total disc replacement. Randomized comparisons of fusion with intensive rehabilitation show similar average improvement in many chronic axial-pain populations, while both pathways have nonresponse and crossover (Chou 2009, PMID 19363455; Phillips 2013, PMID 23334400). Disc replacement is noninferior or modestly superior to fusion on selected endpoints in narrowly eligible one- or two-level DDD, but it introduces implant, approach and late revision risks (Rao 2014, PMID 24323061; Zigler 2012, PMID 23082846). Selection, absolute benefit, adverse events and ten-plus-year durability matter more than the generic operation label.

What surgery is trying to change

Operation Mechanical objective Assumed pain mechanism
Posterolateral fusion Eliminate segment motion Motion-sensitive segment
Interbody fusion Stabilize and restore height/alignment Disc/endplate segment
ALIF Anterior disc removal and interbody fusion Discogenic segment
TLIF/PLIF Posterior/transforaminal interbody fusion Disc plus posterior access needs
Circumferential fusion Anterior and posterior stabilization Maximize fusion construct
Total disc replacement Replace disc while preserving motion Discogenic pain with suitable facets/alignment
Dynamic stabilization Control rather than eliminate motion Motion/load modulation

None of these operations independently validates the preoperative pain source.

Selection

Common requirements for considering elective surgery include:

  • persistent severe pain-related disability;
  • adequate, feasible nonoperative treatment;
  • a defined one- or limited-level target;
  • clinical–imaging concordance;
  • exclusion of hip, SI, facet, inflammatory and serious alternatives;
  • assessment of mood, expectations, smoking and work context;
  • understanding that improvement, not cure, is the goal.

Discography and other prognostic tests have not reliably solved fusion selection (Willems 2013, PMID 23427903).

Fusion versus nonoperative care

Trials compared fusion with intensive cognitive/exercise rehabilitation in selected chronic low-back-pain populations. Reviews conclude that surgery can improve pain and disability, but differences versus structured rehabilitation are small or inconsistent and complications/reoperations matter (Chou 2009, PMID 19363455; Gibson 2005, PMID 15846617).

Evidence issue Consequence
Patients know assignment Expectation and crossover
“Usual care” varies Comparator may be weak
Surgical techniques vary Pooled operation effect is broad
DDD definitions vary Phenotype heterogeneity
Loss to long-term follow-up Late harm/benefit uncertainty
Crossovers Intention-to-treat dilution and selection
Reoperation Must be counted as outcome, not footnote

A systematic review focused on chronic low-back pain attributed to DDD found both fusion and nonoperative care improved outcomes, without a clear large advantage that applies to all imaging-defined disease (Phillips 2013, PMID 23334400).

Clinical reviews of symptomatic lumbar DDD likewise emphasize exhaustive phenotype assessment and nonoperative care before elective reconstruction (Madigan 2009, PMID 19202123).

Fusion outcomes

Meta-analysis of first-time fusion for degenerative disorders found substantial mean pain and disability improvement but wide variation and residual symptoms (Koenders 2019, PMID 29995169).

Outcome Why report Common distortion
ODI mean change Functional impact Mean hides nonresponders
≥MCID responder Individual relevance Threshold varies
Pain NRS Symptom outcome Back vs leg pain mixed
Work participation Real-world function Labor market confounding
Opioid use Treatment burden Indication and baseline dependence
Complication Net benefit Incomplete capture after discharge
Reoperation Durability/failure Different definitions
Fusion status Technical endpoint Does not equal symptom success

Fusion risks

Time Risk
Perioperative Bleeding, infection, vascular/visceral injury, nerve injury, dural tear
Early Thromboembolism, wound failure, ileus, severe pain, readmission
Intermediate Nonunion, hardware failure, persistent pain, donor-site morbidity
Late Adjacent-segment disease, junctional problems, reoperation

Smoking, poor bone health, diabetes, frailty and psychosocial risk can alter outcome. Technique-specific risk differs between anterior, lateral and posterior approaches.

Rehabilitation around fusion

Systematic review found rehabilitation may improve outcomes after lumbar fusion, but programs, timing and certainty vary (Bogaert 2022, PMID 35258644). An RCT-based economic evaluation compared early and later rehabilitation initiation, illustrating that timing affects resources as well as symptoms (Oestergaard 2013, PMID 23928716).

Prehabilitation can address expectations, smoking, nutrition, activity and postoperative self-management; evidence does not support delaying necessary urgent neurological surgery for prolonged conditioning.

Long-term follow-up of a person-centered cognitive-behavioral prehabilitation program provides a durability signal but does not establish that prehabilitation substitutes for appropriate surgical selection (Kemani 2024, PMID 38753831).

Total disc replacement: rationale

Lumbar total disc replacement removes the diseased disc, restores height and aims to preserve motion. Proposed advantages over fusion are reduced adjacent-segment loading and faster recovery; proposed disadvantages are implant wear, migration, subsidence, heterotopic ossification and difficult revision (Janssen 2017, PMID 29176486).

Typical disc-replacement eligibility

More compatible Less compatible/contraindication concern
One or two symptomatic lumbar levels Multilevel diffuse degeneration
Preserved facet joints Advanced facet arthropathy
Adequate bone quality Osteoporosis
No major instability Spondylolisthesis/instability
Suitable vascular/anterior anatomy High approach risk
Axial discogenic phenotype Dominant radiculopathy/stenosis requiring other treatment
Realistic activity expectations Unmanageable expectation mismatch

Eligibility in device trials is narrower than “has DDD.”

Disc replacement versus fusion

Meta-analyses of randomized trials generally find similar or modestly better outcomes for replacement on selected composite success, satisfaction or reoperation endpoints, without universal superiority (Rao 2014, PMID 24323061; Wei 2013, PMID 23645003).

Earlier and later meta-analyses reach broadly similar direction while differing in included devices and endpoints, showing how pooled results change with the technology era (Yajun 2010, PMID 20364392; Yao 2014, PMID 25034746; Patel 2026, PMID 42385251).

Trial/report Comparison Follow-up contribution
CHARITÉ IDE Disc replacement vs fusion Five-year device-era outcomes (PMID 18805066)
ProDisc-L IDE Single-level replacement vs circumferential fusion Five-year outcomes (PMID 23082846)
ProDisc-L early randomized report Arthroplasty vs fusion Two-to-three-year outcomes (PMID 25802580)
ProDisc US early trial Feasibility/device introduction Short follow-up and learning curve (PMID 14560188)
Maverick IDE Arthroplasty vs ALIF Five-year outcomes (PMID 31100723)
Two-level randomized device trial Two-level replacement vs fusion Five-year reoperation (PMID 28005616)
TDR vs nonoperative randomized cohort Adjacent degeneration Eight-year imaging outcome (PMID 29794581)

Device-specific results should not be generalized to all implants or surgeons.

Cost analyses of lumbar replacement versus fusion depend heavily on index hospitalization, rehabilitation, reoperation horizon and payer perspective; early financial comparisons cannot establish lifetime value (Patel 2008, PMID 18836357).

Adjacent-segment degeneration

Fusion may increase motion/stress at adjacent levels, but aging and pre-existing degeneration also drive adjacent change. Radiographic adjacent degeneration and symptomatic adjacent-segment disease are distinct.

The eight-year randomized comparison of disc replacement with nonoperative care found that motion preservation does not eliminate adjacent degeneration and that comparator choice changes causal interpretation (Furunes 2018, PMID 29794581).

Endpoint Definition needed
Radiographic adjacent degeneration Grade/height/osteophyte threshold
Symptomatic adjacent disease New concordant symptoms
Adjacent surgery Reoperation at neighboring level
Index-level failure Pseudarthrosis, migration, wear, stenosis

Reoperation and revision

Five-year two-level randomized data reported lower reoperation rates for total disc replacement than fusion in that device trial (Radcliff 2018, PMID 28005616). Reoperation depends on surgeon threshold, device availability, payer approval and whether removals/revisions are counted consistently.

Anterior implant revision can be technically hazardous because of vascular scarring. Long-term surveillance should include device-specific adverse events, not only patient-reported improvement.

Cervical boundary

Cervical disc arthroplasty has a larger evidence base for radiculopathy/myelopathy than lumbar arthroplasty, but cervical results should not be imported into lumbar axial DDD. Anatomy, indication and failure modes differ (Phillips 2005, PMID 16138062; Radcliff 2017, PMID 29372135).

Dynamic stabilization and emerging devices

Posterior dynamic stabilization seeks intermediate motion control. Prospective cohort comparison with interbody fusion has not established a durable general advantage (Fei 2015, PMID 26031745).

Nucleus replacement and facet replacement remain device-specific strategies requiring registry surveillance. Early feasibility does not answer migration, subsidence, wear or revision over decades.

Interpreting “success”

Composite FDA device success may combine ODI, neurological status, radiographic status, adverse events and reoperation. A statistically higher composite does not reveal which component drove the difference.

Preferred reporting includes:

  1. mean and responder pain/disability;
  2. quality of life and work;
  3. all serious adverse events;
  4. index and adjacent reoperations;
  5. opioid use;
  6. device/fusion technical status;
  7. attrition and crossover;
  8. ten-year or longer surveillance.

Shared decision frame

Question Why it matters
What exact pain phenotype is targeted? Avoid surgery for incidental imaging
What is the best nonoperative comparator? Estimate incremental benefit
What proportion meets a meaningful threshold? Means can overstate typical benefit
What are approach/device-specific harms? Net benefit
What happens if surgery fails? Revision pathway
How long is evidence available? Device lifetime differs from trial horizon
What activities/work are expected? Participation and implant load

Evidence conflicts

Surgical series often show larger gains than randomized comparisons because selection, expectations and weak comparators differ. Device trials may show noninferiority or superiority within narrow eligibility, while guidelines remain cautious for generic axial pain. These are not logically inconsistent: efficacy in a selected device population does not validate surgery for every degenerative MRI.

Evidence deepening: discriminating findings (2026-08-30)

The added evidence below was selected to change interpretation, not merely increase citation count. Each result is kept within its studied phenotype and design.

Evidence Quantified or mechanistic finding Consequence for interpretation
Four-year follow-up of surgical versus non-surgical therapy for chronic low back pain (Brox 2010, PMID 19635718) At four years in two merged randomized trials (124 participants), 24% assigned cognitive intervention crossed to surgery and 23% assigned fusion underwent repeat surgery. Crossover and reoperation make treatment-policy and as-treated estimates answer different questions.
No difference in long-term trunk muscle strength, cross-sectional area, and density in patients with chronic low back pain 7 to 11 years after lumbar fusion versus cognitive intervention and exercises (Froholdt 2011, PMID 21816683) At 7–11 years, randomized fusion and cognitive-exercise groups did not differ in trunk strength, muscle area or density. Structural stabilization did not confer a long-term muscle advantage.
Adjacent Segment Degeneration Versus Disease After Lumbar Spine Fusion for Degenerative Pathology: A Systematic Review With Meta-Analysis of the Literature (Zhang 2016, PMID 26836484) Across 31 studies and 4,206 patients, pooled adjacent-segment degeneration was 5.9% per year (95% CI 4.8–7.2) and clinical disease 1.8% per year (95% CI 1.3–2.4). Radiographic and symptomatic adjacent-segment outcomes must remain separate.
Total disc replacement versus fusion for lumbar degenerative diseases - a meta-analysis of randomized controlled trials (Bai 2019, PMID 31335704) A meta-analysis included 14 randomized comparisons of total disc replacement and fusion. Device-era, eligibility and endpoint differences complicate a single class-effect conclusion.
A comparison of the long-term results of anterior lumbar interbody fusion and total disc arthroplasty: a prospective randomized controlled trial with a mean follow-up of 14 years (Putzier 2025, PMID 40449550) A randomized single-level comparison reported outcomes after a mean 14 years (range 12.2–15.9). Very-long follow-up is essential because early noninferiority cannot capture lifetime revision burden.
Lumbar surgery in work-related chronic low back pain: can a continuum of care enhance outcomes? (Mayer 2014, PMID 24231782) Workers’ compensation fusion series reported return-to-work rates of 26–36%, reoperation of 22–27% and persistent opioid use at two years. Work-system context materially modifies outcome and limits transportability from selected trials.

Controversy carried forward

These additions narrow several claims but do not create a diagnostic gold standard. Where an imaging, molecular or treatment-response signal conflicts with sham-controlled, longitudinal or population evidence, the conflict is retained as a selection and transportability problem rather than resolved by vote.

Open questions

  • Which noninvasive phenotype predicts a larger benefit from fusion than intensive rehabilitation? (Willems 2013, PMID 23427903)
  • Does lumbar disc replacement reduce symptomatic adjacent disease beyond ten years, not only radiographic change? (Furunes 2018, PMID 29794581)
  • How do device-specific revision burdens compare over a full implant lifetime? (Zigler 2012, PMID 23082846)
  • Can registries harmonize reoperation, opioid and work outcomes? (Radcliff 2018, PMID 28005616)
  • What rehabilitation timing and content optimize recovery after each approach? (Bogaert 2022, PMID 35258644)

References

  1. Chou R, Baisden J, Carragee EJ, et al. Surgery for low back pain: a review of the evidence for an American Pain Society Clinical Practice Guideline. Spine. 2009;34(10):1094-109. PMID 19363455
  2. Phillips FM, Slosar PJ, Youssef JA, et al. Lumbar spine fusion for chronic low back pain due to degenerative disc disease: a systematic review. Spine. 2013;38(7):E409-22. PMID 23334400
  3. Rao MJ, Cao SS. Artificial total disc replacement versus fusion for lumbar degenerative disc disease: a meta-analysis of randomized controlled trials. Archives of orthopaedic and trauma surgery. 2014;134(2):149-58. PMID 24323061
  4. Zigler JE, Delamarter RB. Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease. Journal of neurosurgery. Spine. 2012;17(6):493-501. PMID 23082846
  5. Willems P. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion. Acta orthopaedica. Supplementum. 2013;84(349):1-35. PMID 23427903
  6. Gibson JN, Waddell G. Surgery for degenerative lumbar spondylosis. The Cochrane database of systematic reviews. 2005. PMID 15846617
  7. Madigan L, Vaccaro AR, Spector LR, et al. Management of symptomatic lumbar degenerative disk disease. The Journal of the American Academy of Orthopaedic Surgeons. 2009;17(2):102-11. PMID 19202123
  8. Koenders N, Rushton A, Verra ML, et al. Pain and disability after first-time spinal fusion for lumbar degenerative disorders: a systematic review and meta-analysis. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2019;28(4):696-709. PMID 29995169
  9. Bogaert L, Thys T, Depreitere B, et al. Rehabilitation to improve outcomes of lumbar fusion surgery: a systematic review with meta-analysis. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2022;31(6):1525-1545. PMID 35258644
  10. Oestergaard LG, Christensen FB, Nielsen CV, et al. Early versus late initiation of rehabilitation after lumbar spinal fusion: economic evaluation alongside a randomized controlled trial. Spine. 2013;38(23):1979-85. PMID 23928716
  11. Kemani MK, Hanafi R, Brisby H, et al. Long-Term Follow-Up of a Person-Centered Prehabilitation Program Based on Cognitive-Behavioral Physical Therapy for Patients Scheduled for Lumbar Fusion. Physical therapy. 2024;104(8). PMID 38753831
  12. Janssen M, Garcia R, Miller L, et al. Challenges and Solutions for Lumbar Total Disc Replacement Implantation. Spine. 2017;42 Suppl 24:S108-S111. PMID 29176486
  13. Wei J, Song Y, Sun L, et al. Comparison of artificial total disc replacement versus fusion for lumbar degenerative disc disease: a meta-analysis of randomized controlled trials. International orthopaedics. 2013;37(7):1315-25. PMID 23645003
  14. Yajun W, Yue Z, Xiuxin H, et al. A meta-analysis of artificial total disc replacement versus fusion for lumbar degenerative disc disease. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2010;19(8):1250-61. PMID 20364392
  15. Yao L, Wang T, Liu Y, et al. [Comparison of total disc replacement versus fusion for lumbar degenerative disc disease: a Meta-analysis of randomized controlled trials]. Zhonghua wai ke za zhi [Chinese journal of surgery]. 2014;52(5):370-5. PMID 25034746
  16. Patel S, Mendonca A, Nischal SA, et al. Total disc replacement versus lumbar interbody fusion for degenerative disc disease: a meta-analysis of randomized controlled trials. Neurosurgical focus. 2026;61(1):E11. PMID 42385251
  17. Guyer RD, McAfee PC, Banco RJ, et al. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up. The spine journal : official journal of the North American Spine Society. 2009;9(5):374-86. PMID 18805066
  18. Zigler JE, Sachs BL, Rashbaum RF, et al. Two- to 3-Year Follow-Up of ProDisc-L: Results From a Prospective Randomized Trial of Arthroplasty Versus Fusion. SAS journal. 2007;1(2):63-7. PMID 25802580
  19. Delamarter RB, Fribourg DM, Kanim LE, et al. ProDisc artificial total lumbar disc replacement: introduction and early results from the United States clinical trial. Spine. 2003;28(20):S167-75. PMID 14560188
  20. Gornet MF, Burkus JK, Dryer RF, et al. Lumbar disc arthroplasty versus anterior lumbar interbody fusion: 5-year outcomes for patients in the Maverick disc investigational device exemption study. Journal of neurosurgery. Spine. 2019;31(3):347-356. PMID 31100723
  21. Radcliff K, Spivak J, Darden B, et al. Five-Year Reoperation Rates of 2-Level Lumbar Total Disk Replacement Versus Fusion: Results of a Prospective, Randomized Clinical Trial. Clinical spine surgery. 2018;31(1):37-42. PMID 28005616
  22. Furunes H, Hellum C, Espeland A, et al. Adjacent Disc Degeneration After Lumbar Total Disc Replacement or Nonoperative Treatment: A Randomized Study with 8-year Follow-up. Spine. 2018;43(24):1695-1703. PMID 29794581
  23. Patel VV, Estes S, Lindley EM, et al. Lumbar spinal fusion versus anterior lumbar disc replacement: the financial implications. Journal of spinal disorders & techniques. 2008;21(7):473-6. PMID 18836357
  24. Phillips FM, Garfin SR. Cervical disc replacement. Spine. 2005;30(17 Suppl):S27-33. PMID 16138062
  25. Radcliff K, Davis RJ, Hisey MS, et al. Long-term Evaluation of Cervical Disc Arthroplasty with the Mobi-C© Cervical Disc: A Randomized, Prospective, Multicenter Clinical Trial with Seven-Year Follow-up. International journal of spine surgery. 2017;11(4):31. PMID 29372135
  26. Fei H, Xu J, Wang S, et al. Comparison between posterior dynamic stabilization and posterior lumbar interbody fusion in the treatment of degenerative disc disease: a prospective cohort study. Journal of orthopaedic surgery and research. 2015;10:87. PMID 26031745
  27. Brox JI, Nygaard ØP, Holm I, Keller A, Ingebrigtsen T, Reikerås O, et al. Four-year follow-up of surgical versus non-surgical therapy for chronic low back pain. Annals of the rheumatic diseases. 2010;69(9):1643-8. PMID 19635718
  28. Froholdt A, Holm I, Keller A, Gunderson RB, Reikeraas O, Brox JI, et al. No difference in long-term trunk muscle strength, cross-sectional area, and density in patients with chronic low back pain 7 to 11 years after lumbar fusion versus cognitive intervention and exercises. The spine journal : official journal of the North American Spine Society. 2011;11(8):718-25. PMID 21816683
  29. Zhang C, Berven SH, Fortin M, Weber MH. Adjacent Segment Degeneration Versus Disease After Lumbar Spine Fusion for Degenerative Pathology: A Systematic Review With Meta-Analysis of the Literature. Clinical spine surgery. 2016;29(1):21-9. PMID 26836484
  30. Bai DY, Liang L, Zhang BB, Zhu T, Zhang HJ, Yuan ZG, et al. Total disc replacement versus fusion for lumbar degenerative diseases - a meta-analysis of randomized controlled trials. Medicine. 2019;98(29):e16460. PMID 31335704
  31. Putzier M, Fussi J, Khakzad T, Lindemann C, Zippelius TK, Strube P, et al. A comparison of the long-term results of anterior lumbar interbody fusion and total disc arthroplasty: a prospective randomized controlled trial with a mean follow-up of 14 years. The bone & joint journal. 2025;107-B(6):639-648. PMID 40449550
  32. Mayer TG, Gatchel RJ, Brede E, Theodore BR. Lumbar surgery in work-related chronic low back pain: can a continuum of care enhance outcomes? The spine journal : official journal of the North American Spine Society. 2014;14(2):263-73. PMID 24231782